ESHG\uff08European Society of Human Genetics\uff09<\/strong> AUA\uff08American Urological Association<\/strong>\uff09<\/strong> AUA\uff08American Urological Association\uff09<\/strong> AUA\uff08American Urological Association\uff09<\/strong> AACR\uff08American Association for Cancer Research\uff09<\/strong> AACR\uff08American Association for Cancer Research\uff09<\/strong> EAU\uff08European Association of Urology\uff09\uff5cOral<\/strong> ASCO-GU\uff5cPoster<\/strong> ESMO Asia\uff5cPoster<\/strong> UAA\uff08Urological Association of Asia\uff09\uff5cPoster<\/strong> SIU\uff08Soci\u00e9t\u00e9 Internationale d'Urologie\uff09\uff5cPoster<\/strong> AUA\uff5cPoster<\/strong> AUA\uff5cPodium<\/strong> AACR\uff5cPoster<\/strong> AACR\uff5cPoster<\/strong> ASCO-GU\uff5cPoster<\/strong> 13th AACR-JCA Joint Conference\uff5cPoster<\/strong> ESMO Asia\uff5cPoster<\/strong> AUA\uff5cPodium<\/strong> EAU\uff5cPoster<\/strong> AACR\uff5cPoster<\/strong> AACR\uff5cPoster<\/strong> EAU\uff5cPodium<\/strong> ASCO-GU\uff5cPoster<\/strong> AACR\uff5cPoster<\/strong> ASCO-GU\uff5cPoster<\/strong> AUA\uff5cWeb<\/strong> <\/p>\n","protected":false},"excerpt":{"rendered":" 2026\u5e74 ESHG\uff08European Society of Human Genetics\uff09Watanabe R. Spatial transcriptomic profiling of TSC-associated a […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":385,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"sns_share_botton_hide":"","vkExUnit_sns_title":"","_vk_print_noindex":"","sitemap_hide":"","vkExUnit_sitemap":"","_veu_custom_css":"","veu_display_promotion_alert":"","_exclude_from_list_pages":"","vkexunit_cta_each_option":"","vkExUnit_childPageIndex":"","vkExUnit_pageList_ancestor":"","vkExUnit_contact_enable":"","_lightning_design_setting":{"layout":"col-one-no-subsection"},"footnotes":""},"class_list":["post-413","page","type-page","status-publish","hentry"],"veu_head_title_object":{"title":"","add_site_title":""},"_links":{"self":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/pages\/413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/comments?post=413"}],"version-history":[{"count":2,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/pages\/413\/revisions"}],"predecessor-version":[{"id":416,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/pages\/413\/revisions\/416"}],"up":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/pages\/385"}],"wp:attachment":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/media?parent=413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Watanabe R. Spatial transcriptomic profiling of TSC-associated angiomyolipoma reveals molecular heterogeneity distinct from sporadic AML<\/em><\/p>\n\n\n\n
Watanabe R. Vascular PSMA expression drives angiogenesis and recurrence in renal cell carcinoma and represents a rationale for PSMA-targeted therapy<\/em><\/p>\n\n\n\n
Watanabe R. Spatial transcriptomics reveals clonal evolution from Gleason grade group 1 cancer to intraductal carcinoma of the prostate<\/em><\/p>\n\n\n\n
Watanabe R. Spatial transcriptomic profiling of TSC-associated angiomyolipoma reveals molecular heterogeneity distinct from sporadic AML<\/em><\/p>\n\n\n\n
Watanabe R. Spatial transcriptomic dissection of TSC-associated angiomyolipoma reveals microenvironmental programs driven by mTORC1 dysregulation<\/em><\/p>\n\n\n\n
Watanabe R. PSMA-expressing tumor vasculature in renal cell carcinoma: spatial, functional, and therapeutic implications<\/em><\/p>\n\n\n\n
Watanabe R. Spatial and functional analysis of PSMA-positive tumor vessels as predictors of recurrence and potential therapeutic targets in renal cell carcinoma<\/em><\/p>\n\n\n\n
Watanabe R. Use of spatial transcriptomics to analyze the molecular landscape of tuberous sclerosis complex associated angiomyolipoma: Implications for diagnosis and therapeutic targeting<\/em><\/p>\n\n\n\n2025\u5e74<\/h3>\n\n\n\n
Watanabe R. Spatial Transcriptomic Profiling Reveals Distinct Molecular Features of Tuberous Sclerosis-Associated Renal Angiomyolipomas<\/em><\/p>\n\n\n\n
Watanabe R. Evaluation of Angiogenic Potential in PSMA-Positive Tumor Vessels Surrounding Renal Cell Carcinoma Using High-Resolution Spatial Gene Expression Analysis<\/em><\/p>\n\n\n\n
Watanabe R. Spatial and Molecular Analysis of PSMA-Positive Peritumoral Vessels in Renal Cell Carcinoma<\/em><\/p>\n\n\n\n
Watanabe R. PSMA-positive tumor vessels surrounding renal cell carcinoma exhibit high angiogenic potential and serve as a predictor of tumor recurrence<\/em><\/p>\n\n\n\n
Watanabe R. Identifying Gene Expression Pattern in Intraductal Carcinoma of the Prostate Using Spatial Gene Expression Analysis and Its Potential for New Biomarkers and Treatments<\/em><\/p>\n\n\n\n
Watanabe R. The vesicle component released from renal cell carcinoma cells transforms tumor blood vessels into PSMA-positive and enhances angiogenic potential<\/em><\/p>\n\n\n\n
Watanabe R. Identifying gene expression patterns in intraductal carcinoma of the prostate using spatial gene expression analysis: Potential for new biomarkers and treatments<\/em><\/p>\n\n\n\n
Watanabe R. PSMA-positive tumor vessels around renal cell carcinoma with high angiogenic potential as therapeutic targets and predictors of tumor recurrence<\/em><\/p>\n\n\n\n
Watanabe R. Spatial transcriptomics can illuminate unfamiliar insights into the gene expression profiles of rare prostate cancer subtypes<\/em><\/p>\n\n\n\n2024\u5e74<\/h3>\n\n\n\n
Watanabe R. PSMA-positive tumor vessels around renal cancer have high tumor angiogenic potential and predict tumor recurrence<\/em><\/p>\n\n\n\n
Watanabe R. A genetic landscape of de novo neuroendocrine prostate cancer and possible novel therapeutic strategies unveiled by spatial gene expression analysis<\/em><\/p>\n\n\n\n
Watanabe R. Exploring the Genomic Blueprint of de novo Neuroendocrine Prostate Cancer: Insights for Innovative Therapies from Spatial Gene Expression Analysis<\/em><\/p>\n\n\n\n
Watanabe R. Exploring the Genomic Blueprint of de novo Neuroendocrine Prostate Cancer: Insights for Innovative Therapies from Spatial Gene Expression Analysis<\/em><\/p>\n\n\n\n2023\u5e74<\/h3>\n\n\n\n
Watanabe R. Detection of Intraductal Carcinoma of the Prostate (IDCP) cases focusing on high-grade prostatic intraepithelial neoplasia (PIN) findings regarding invasive carcinoma of the prostate<\/em><\/p>\n\n\n\n
Watanabe R. Detection of Intraductal Carcinoma of the Prostate (IDCP) cases focusing on high-grade prostatic intraepithelial neoplasia (PIN) findings regarding invasive carcinoma of the prostate<\/em><\/p>\n\n\n\n
Watanabe R. Detection of Intraductal Carcinoma of the Prostate (IDCP) cases focusing on high-grade prostatic intraepithelial neoplasia (PIN) findings regarding invasive carcinoma of the prostate<\/em><\/p>\n\n\n\n2022\u5e74<\/h3>\n\n\n\n
Watanabe R. Effect of PSMA-positive membranes secreted from prostate cancer cells on vascular endothelial cells<\/em><\/p>\n\n\n\n
Watanabe R. Effect of PSMA-positive membranes secreted from prostate cancer cells on vascular endothelial cells<\/em><\/p>\n\n\n\n2020\u5e74<\/h3>\n\n\n\n
Watanabe R. The novel role of SPOP in regulating topoisomerase 2A in prostate cancer cells as a potential therapeutic marker for DNA repair targeted therapy<\/em><\/p>\n\n\n\n